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OBJECTIVE — To investigate whether a pragmatic structured education program with and
without pedometer use is effective for promoting physical activity and improving glucose toler-
ance in those with impaired glucose tolerance (IGT).
RESEARCH DESIGN AND METHODS — Overweight and obese individuals with IGT
were recruited from ongoing screening studies at the University Hospitals of Leicester, U.K.
Participantswererandomlyassignedtooneofthreegroups.Group1receiveda3-hgroup-based
structured education program designed to promote walking activity using personalized steps-
per-day goals and pedometers. Group 2 received a 3-h group-based structured education pro-
gram designed to promote walking activity using generic time-based goals. Group 3 received a
brief information leaﬂet (control condition). Outcomes included an oral glucose tolerance test,
standardanthropometricmeasures,ambulatoryactivity,andpsychologicalvariables.Follow-up
was conducted at 3, 6, and 12 months.
RESULTS — A total of 87 individuals (66% male, mean age 65 years) were included in this
study. At 12 months, signiﬁcant decreases in 2-h postchallenge glucose and fasting glucose of
1.31 mmol/l (95% CI 2.20 to 0.43) and 0.32 mmol/l (0.59 to 0.03), respectively,
were seen in the pedometer group compared with the control group. No signiﬁcant improve-
ments in glucose control were seen in those given the standard education program.
CONCLUSIONS — This study suggests that a pragmatic structured education program that
incorporates pedometer use is effective for improving glucose tolerance in those with IGT. This
resultislikelytohaveimportantimplicationsforfutureprimarycare–baseddiabetesprevention
initiatives.
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L
ifestyle intervention programs have
successfully reduced the risk of type
2 diabetes in high-risk individuals in
diverse settings (1). However, the diabe-
tes prevention programs evaluated have
tendedtouseresource-intensivebehavior
change strategies that may be difﬁcult to
implement in usual health care practice,
given resource and infrastructure limita-
tions (2,3). Furthermore, although phys-
icalinactivityisoneofthemostimportant
lifestyle determinants contributing to the
rising prevalence of type 2 diabetes, there
is little direct evidence that previous dia-
betes prevention programs have been
successful for promoting clinically signif-
icant increases in physical activity (4).
Therefore, studies with the aim of devel-
oping and evaluating pragmatic physical
activity interventions in at-risk individu-
als are needed.
The Prediabetes Risk Education and
Physical Activity Recommendation and
Encouragement (PREPARE) structured
education program was developed in re-
sponse to this need. The PREPARE pro-
gram is designed to promote walking
activity through pedometer use in those
with impaired glucose tolerance (IGT) (5).
The primary aim of this study was to
testthehypothesisthatthePREPAREpro-
gram is effective for improving glucose
tolerance after 12 months in individuals
with IGT. The secondary aim of the study
was to test experimentally the role of the
pedometer in promoting sustained be-
haviorchange.Thisinformationisimpor-
tant because the National Institute for
Health and Clinical Excellence, U.K., guid-
ance on methods to increase physical activ-
ity highlights the lack of evidence for
pedometer use as an adjunct to existing
methodsofpromotingbehaviorchange(6).
RESEARCH DESIGN AND
METHODS— Participants were re-
cruited from ongoing population-based
diabetes screening programs in Leicester,
U.K., between September 2006 and
March 2007; the study was completed in
April 2008. Overweight or obese individ-
uals (BMI 25 or 23 kg/m
2 for South
Asians) with screening-detected IGT (7)
were contacted by letter and follow-up
telephone call by a member of their
screening team and invited to take part in
the study. Individuals were recruited into
the study within 12 months of their
screening visit. As part of the screening
programs, all individuals had their phys-
ical activity levels assessed by the short
versionoftheinternationalphysicalactiv-
ity questionnaire (IPAQ) (8). Individuals
who reported taking steroids were
excluded.
All applicable institutional and gov-
ernmental regulations concerning the
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lowed during this research. This study
was approved by the Leicestershire,
Northamptonshire, and Rutland National
Health Service Research Ethics Commit-
tee in June 2006.
Treatment regimens and
randomization
Participants were randomly assigned,
using a block design, to receive either
usual care, the PREPARE program, or
the PREPARE program without pedome-
ter use and were stratiﬁed by age and sex.
Participant random assignment was con-
ductedusingopaqueenvelopesandaran-
domly generated number sequence by a
member of our research team with no
prior knowledge of recruited individuals
other than their age and sex. Participants
were informed of their allocated group by
a member of our research team once their
baseline measurements were completed.
PREPARE program
The theoretical underpinning, design,
and content of the PREPARE program
have been described in detail elsewhere
(5). In brief, it is a single-session group-
basededucationprogram.Theprogramis
180 min long; 105 min are dedicated to
addressing the causes, complications,
timeline, and identity of IGT and 75 min
are targeted to addressing the perceived
effectiveness of exercise as a treatment for
IGT, walking self-efﬁcacy beliefs, barriers
to walking, and self-regulatory strategies.
The program has a written curriculum,
modeled on the person-centered philoso-
phy and learning techniques developed
for the Diabetes Education and Self-
Management for Ongoing and Newly Di-
agnosed (DESMOND) program (9–11),
an established nationally available 6-h
structured educational program designed
to promote lifestyle change and self-
management for those with newly diag-
nosed type 2 diabetes in the U.K.
As part of the program, participants
were provided with a pedometer (SW-
200; Yamax, Tokyo, Japan) and encour-
aged to set personalized steps-per-day
goals based on their baseline ambulatory
activity level. Sedentary participants were
encouraged to increase their activity lev-
els by at least 3,000 steps per day, equiv-
alent to 30 min of walking (12). Those
achieving 6,000 steps per day were en-
couraged to try to reach at least 9,000
steps per day, an amount that is likely to
include 30 min of walking activity in ad-
dition to usual daily activity (12). Those
achieving 9,000 steps per day were en-
couragedtoatleastmaintaintheircurrent
activity levels and were informed that
health beneﬁts could be achieved by in-
creasing their activity levels further. Goal
attainment was encouraged through the
use of proximal objectives, such as in-
creasing ambulatory activity by 500 steps
per day every 2 weeks. Participants were
enabled to set an action plan detailing
where, when, and how their ﬁrst proxi-
mal goal would be reached and encour-
aged to repeat this process for each new
proximal goal. They were also encour-
aged to wear their pedometer on a daily
basisandtoself-monitortheirambulatory
activity using a steps-per-day log.
PREPARE program without
pedometer use
This group received the PREPARE pro-
gram, but instead of receiving pedome-
ters, participants were encouraged to set
time-based goals designed to match the
advice given to the pedometer group.
Sedentaryindividualswereencouragedto
trytoachieveatleast30minofmoderate-
intensity physical activity per day. Those
already achieving 30 min of moderate-
intensity physical activity were encour-
aged to at least maintain their current
activity levels and were informed that
health beneﬁts could be achieved by in-
creasing their activity levels further. As
with the pedometer group, participants
were encouraged to set proximal goals,
such as increasing moderate-intensity ac-
tivity by 5 min/day every 2 weeks, form
action plans, and record their daily activ-
ity levels. Individuals wishing to set vig-
orous-intensity activity goals were
advised that they should consult their
general practitioner before commencing
the program.
Intervention delivery and follow-up
Both versions of the PREPARE program
were delivered by two educators trained
through the DESMOND program. Pro-
grams were delivered at the Diabetes Re-
search Unit, Leicester Royal Inﬁrmary,
U.K., within 1 month of baseline mea-
surements. Individuals in both interven-
tion groups also received a brief (10-min)
review of progress during their 3- and
6-month clinical measurement session
delivered by the same educators who had
delivered the initial educational program.
Usual care
Participants randomly assigned to the
control group were sent a brief informa-
tion sheet in the mail, detailing the likely
causes, consequences, symptoms, and
timeline associated with IGT, along with
information about how physical activity
canbeusedtotreat/controlthecondition.
Measures
All outcomes were measured at baseline
and at 3, 6, and 12 months; 2-h glucose
was the primary outcome, and all other
outcomes were secondary.
Biochemical analysis
At their baseline appointments, partici-
pants underwent an oral glucose toler-
ance test (fasting and 2-h glucose).
Participants arrived at their appointment
after a 12-h fast and 24 h of avoiding vig-
orous exercise. Those with a diagnosis
type 2 diabetes at baseline were excluded
from the study (7). All biochemical anal-
yseswereconductedblindedtotreatment
group.
Plasma glucose was measured using a
glucose oxidase method on the Beckman
AutoAnalyzer (Beckman, High Wy-
combe, U.K.). Serum cholesterol was an-
alyzedusingacholesterolenzymaticassay
(Abbott Clinical Chemistry, Chicago, IL).
HDL cholesterol was analyzed using the
ultra-HDL assay (Abbott Clinical Chem-
istry). Serum triglyceride was analyzed
using the triglyceride glycerol phosphate
oxidase assay (Abbott Clinical Chemis-
try). Biochemical measurements were
performed in the same laboratory located
within Leicester Royal Inﬁrmary using
stable methodology standardized to ex-
ternal quality assurance reference values.
Physical activity
Physical activity was measured objec-
tively by pedometer and subjectively by
questionnaire. Sealed piezoelectric pe-
dometers with a 7-day memory (NL-800;
NEW-LIFESTYLES, Lee’s Summit, MO)
were used to measure ambulatory activ-
ity.Thesepedometersweredifferentfrom
the motivational instruments used in the
primary intervention condition and have
been shown to be more accurate than tra-
ditional spring-levered pedometers in
overweight and obese individuals (13).
For the purposes of this study at least 3
valid days of data were required; a valid
day constituted at least 12 h of wear time.
Physical activity was also measured us-
ing the long last-7-days self-administered
format of the IPAQ. This questionnaire
provides a measure of walking and other
moderate- to vigorous-intensity activities
carried out for 10 continuous minutes
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during leisure time. The IPAQ has been
shown to have reasonable validity com-
pared with accelerometer data ( 0.4)
and test-retest reliability ( 0.7) in the
U.K. (8).
Psychological analysis
Perceptions and perceived knowledge
of IGT. Perceptions and perceived
knowledge of IGT were measured with
the validated brief illness perceptions
questionnaire (14). This instrument was
used to measure ﬁve cognitive illness rep-
resentations (consequences, timeline,
personal control, treatment, and symp-
tom load attributed to IGT), two emo-
tional representations (concern and
negative emotion affect attributed to hav-
ing IGT), and perceived knowledge of
IGT. Each item was answered using an
11-point Likert scale.
Self-efﬁcacy. Participants’ conﬁdence in
their ability to exercise in the face of ﬁve
commonly identiﬁed barriers (tired, bad
mood,badweather,lackoftime,andhol-
iday) was measured using an 11-point
Likert scale (15).
Demographic and anthropometric
data
Arterial blood pressure was measured in
the sitting position (Omron Healthcare,
Henﬁeld, U.K.); three measurements
were obtained and the average of the last
two measurements was used. Body
weight (Tanita TBE 611 scale; Tanita,
WestDrayton,U.K.),waistcircumference
(midpoint between the lower costal mar-
gin and iliac crest), and height were also
measured to the nearest 0.1 kg and 0.5
cm, respectively. Information on current
smoking status, medication history, and
ethnicity were obtained by self-report.
Data analysis
Basedonapowerof80%,asigniﬁcanceof
0.05, and a SD of 1 mmol/l and allowing
for a 50% dropout rate (noncompleters
and those diagnosed with type 2 diabetes
at baseline), 34 participants were re-
quired per group to detect a 1 mmol/l dif-
ferencein2-hglucoselevelsbetweeneach
intervention group and control group at
12 months. Those not attending the ﬁnal
12-month follow-up measurement ses-
sion and those diagnosed with type 2 di-
abetes at baseline were excluded from the
analysis. Those diagnosed with type 2 di-
abetes at 3 and 6 months (n  4) were
treated according to the screening studies
from which they were recruited and had
subsequentfollow-updataimputedusing
their last observation carried forward. To
have numeric parity across time points,
missing biochemical, pedometer, and
anthropometric data at 3 months (n  2)
and 6 months (n2), resulting from those
not attending all intermediary follow-up
sessions, were imputed using the next
observation carried backward. All indivi-
dualsincludedintheanalysiswereanalyzed
in the group to which they were assigned.
Between-group comparisons of change
in measured outcomes at 3, 6, and 12
months were conducted using ANCOVA
procedures; baseline data were included
as a covariate. Each intervention group
was compared with the control group us-
ing simple a priori contrasts; because this
study had one primary hypothesis, ad-
justment was not made for multiple
group, time, or outcome comparisons.
Nonetheless, secondary outcomes were
interpretedwithcautionandinrelationto
the overall pattern of results. All variables
werecheckedfornormalityusingtheKol-
mogorov-Smirnov test and visual inspec-
tion after the removal of extreme outliers
(a value at least 4 SD from the mean).
Tests were two-sided; P  0.05 was con-
sidered signiﬁcant. All analysis was car-
ried out with SPSS 14.0 for Windows
(SPSS, Chicago, IL).
RESULTS— The trial proﬁle is shown
in Fig. 1. Of 326 individuals invited to
take part in the study, 103 (32%) con-
sented. Those who consented to take part
hadsimilarlevelsofself-reportedwalking
and overall physical activity and were of
an age and ethnicity similar to those who
declined the invitation; however, more
men than women agreed to take part
(63% of study participants were male
compared with 55% of those invited to
take part; P  0.03). Five individuals
wereexcludedfromthestudyatbaseline
because of a diagnosis of type 2 diabe-
tes. Over the course of the trial diabetes
was diagnosed in three individuals in
the control group and one individual in
theeducationgroupwithoutpedometer
use; no cases of diabetes were observed
in those given the pedometer version of
the PREPARE program. Eleven partici-
pants were lost to 12-month follow-up.
There were no signiﬁcant demographic,
biochemical, or lifestyle differences at
baseline between attendees and nonat-
tendees at 12 months.
Baseline demographic, anthropomet-
ric, biochemical, and lifestyle characteris-
tics of the study participants are shown in
Table 1; the majority of participants were
inactive based on pedometer counts (12).
There was no signiﬁcant difference be-
tweengroupsinanyofthemeasuredvari-
ables at baseline; however, levels of self-
reported physical activity were sub-
stantially, although not signiﬁcantly, higher
in the pedometer group.
Glucose regulation and physical
activity
Table 2 shows changes in measures of
physicalactivityandglucoseregulationat
3, 6, and 12 months; the intervention ef-
fect for each intervention group is also
provided. Two-hour glucose decreased
signiﬁcantly in the pedometer group
compared with that in the control group
at 3 months (1.46 mmol/l, 95% CI
2.36 to 0.56) and 12 months (1.31
mmol/l, 2.20 to 0.43). Fasting glu-
cosealsodecreasedsigniﬁcantlyinthepe-
dometer group compared with that in the
control group at 3 months (0.37
mmol/l, 0.63 to 0.11), 6 months
(0.30mmol/l,0.57to0.03),and12
months (0.32 mmol/l, 0.59 to
0.03). There was no difference in either
fasting or 2-h glucose in those given the
education program without pedometer
use compared with that in the control
group at any follow-up time point.
Objectively measured ambulatory ac-
tivity and self-reported walking and over-
all moderate- to vigorous-intensity
physical activity increased signiﬁcantly in
the pedometer group compared with
those in the control group at 3, 6, and 12
months. In the group without pedometer
use,ambulatoryactivityandself-reported
walking and moderate- to vigorous-
intensity physical activity increased sig-
niﬁcantly compared with those in the
control group at 12 months; however,
there was no signiﬁcant increase in any
measure of physical activity in this group
compared with that in the control group
at 3 or 6 months.
Lipids, blood pressure, and body
weight
There was no difference in measured
blood lipids, body weight, waist circum-
ference, or blood pressure in either of the
interventiongroupscomparedwiththatin
the control group at any time point (sup-
plementary Table A1, available in an online
appendix at http://care.diabetesjournals.
org/cgi/content/full/dc09-0130/DC1).
Physical activity and glucose tolerance
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Compared with the control group, both
intervention groups achieved signiﬁcant
increases in perceived knowledge of IGT,
perceived effectiveness of exercise as a
treatmentforIGT,andself-efﬁcacybeliefs
at 12 months (supplementary Table A2,
available in an online appendix). No sig-
niﬁcant differences were seen in other
measured illness perception or emotional
representations.
CONCLUSIONS— This study showed
that group-based structured education
designed to promote increased walking
activity through pedometer use is effec-
tive for improving glucose tolerance in
those with screening-detected IGT,
whereas the same program without pe-
dometer use did not result in improved
glucose tolerance. The decrease in 2-h
glucoseseeninthepedometergroupat12
months of 1.31 mmol/l (95% CI 2.20
to 0.43) is greater than that reported in
previous lifestyle diabetes prevention
programs. For example a meta-analysis of
eightstudiesreportedanoverallinterven-
tioneffectin2-hglucoseof0.84mmol/l
(1.29 to 0.39) at 12 months and a
reduction in relative risk of developing
type 2 diabetes of 0.55 (0.44–0.69) (16).
Those in the pedometer group also
achieved a signiﬁcant decrease in fasting
glucose of 0.32 mmol/l (0.59 to
0.03)comparedwiththatinthecontrol
group; this is in contrast to previous dia-
betes prevention programs in which life-
style change had consistently failed to
reduce fasting plasma glucose levels (3).
However, a recent study in individuals
with a family history of type 2 diabetes
reported that change in physical activity,
as measured by accelerometers, was asso-
ciatedwithchangeinfastingglucoseat12
months (17).
It has been suggested that weight loss
was the primary determinant of the re-
duced risk of developing type 2 diabetes
observed in previous lifestyle diabetes
prevention programs (4,18), in part be-
cause these programs have only demon-
strated small increases in physical activity
(4). In contrast, although no changes to
body weight or waist circumference were
observed in this study, substantial in-
creases in ambulatory activity of 2,000
steps per day, equivalent to 140 min of
moderate-intensity walking activity per
week (12), were seen in the pedometer
groupcomparedwiththecontrolgroupat
each follow-up time point. The results of
this study are consistent with numerous
mechanisms linking physical activity di-
rectly to reduced insulin resistance and
improved glucose control (19). In the
group given the education program with-
outpedometeruse,therelativelylowlevel
of ambulatory activity at 12 months
and/or the lack of sustained increases in
physical activity across the study period
may explain why glucose levels were
unchanged.
The lack of an intervention effect on
cholesterol and blood pressure levels is
consistent with a study in individuals
with a family history of type 2 diabetes,
which showed that change in overall
physical activity, as measured by accel-
erometers, was signiﬁcantly associated
with reductions in fasting insulin and glu-
cose, but not with blood pressure or HDL
Figure 1—PREPARE program study proﬁle.
Yates and Associates
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adiposity (17). Another prospective study
usingobjectivelymeasuredphysicalactivity
energy expenditure reported similar ﬁnd-
ings (20). The PREPARE program study
adds to this evidence by suggesting that in
individuals with IGT, of whom many were
taking antihypertensive and/or statin medi-
cation, glucose regulation is more sensitive
to change than blood pressure or choles-
terol with increased physical activity.
Both versions of the PREPARE pro-
gram positively inﬂuenced several of the
key psychological determinants on which
the program was grounded. This ﬁnding
suggeststhatthepedometerwascrucialin
promoting the self-regulatory strategies
needed to convert the motivational im-
pact of the education program into sus-
tained behavior change and improved
glucose tolerance. This study adds to ev-
idence from other intervention studies
thathaveconsistentlyshownthatpedom-
eter-based programs are successful at ini-
tiating increased ambulatory activity in
thosewithtype2diabetesandthegeneral
population over the short-term (6
months) (21).
This study has several important lim-
itations. First, the small sample size pre-
cluded meaningful subgroup analysis,
whichisimportant,giventheheterogene-
ity of the study sample. Second, the study
wasconductedinasinglecenterbyaded-
icated research team; this limits the gen-
eralizability of the ﬁndings. However, the
interventionusedinthistrialwasrobustly
developed according to established crite-
riafordevelopingandevaluatingcomplex
interventions which included a theory,
modeling, and exploratory trial phase;
therefore, this study is reproducible (22).
Third, the methodology of this study did
not allow us to determine whether the
success of the pedometer version of the
PREPARE program was solely or partly
due to the reactivity of wearing a pedom-
eter and keeping a daily step count log.
However, studies have shown that the re-
activity of wearing an open pedometer in
adults is minimal and likely to be tempo-
rary(23,24),suggestingthatsomeformof
additional support is required to facilitate
sustained behavior change.
These limitations notwithstanding,
this study is the ﬁrst randomized con-
trolled trial to show behavior change and
improvedglucosetoleranceinindividuals
with IGT after a pragmatic structured ed-
ucation program. Traditional diabetes
prevention programs have used intensive
counseling strategies that would be difﬁ-
culttodeliverina“realworld”healthcare
setting; for example, the Finnish Diabetes
PreventionStudyreportedamedianof20
counseling sessions per patient over the
4-year intervention period (25). There-
fore, pragmatic interventions that are
compatible with the infrastructure and
resources available to national health
services are required. The PREPARE pro-
gram study suggests one possible ap-
proach in the U.K., not least because it
could use existing national and regional
educator training and the quality assur-
ance and development infrastructure that
havebeendevelopedfordeliveringtype2
diabetes self-management programs,
Table 1—Clinical, lifestyle, and demographic characteristics of study participants overall and by group at baseline
Total Control PREPARE
PREPARE with
pedometer
n 87 29 29 29
Age 65  86 5  10 64  76 6  8
Sex
Male 57 (66) 17 (59) 20 (69) 20 (69)
Female 30 (34) 12 (41) 9 (31) 9 (31)
Ethnicity
White 65 (75) 20 (69) 20 (69) 25 (86)
South Asian 21 (24) 9 (31) 8 (31) 4 (14)
Black 1 (1) 0 (0) 1 (3) 0 (0)
Blood pressure medication
-Blockers 29 (34) 10 (34) 11 (38) 8 (28)
ACE inhibitors 17 (20) 5 (19) 4 (14) 8 (28)
Statins 47 (55) 17 (57) 14 (48) 16 (55)
Smoking status 8 (9) 5 (17) 2 (7) 1 (3)
Pedometer counts (steps per day) 6,681  3,462 6,873  3,537 6,560  4,424 6,600  2,402
Self-reported walking activity (MET-min/week) 990 (445–2,123) 801 (292–2,161) 891 (297–2079) 1,386 (594–2,772)
Total self-reported energy expenditure
(MET-min/week)
2,580 (1,180–4,719) 2,335 (923–3,921) 2,359 (947–3,989) 3,480 (1,524–6,339)
BMI (kg/m
2) 29.2  4.7 29.8  4.4 29.5  4.9 28.7  4.8
Waist circumference (cm) 102  11 103  9 103  11 99  12
Weight (kg) 80.8  15.1 81.1  15.0 81.9  14.2 79.4  16.4
Systolic blood pressure (mmHg) 142  16 141  15 144  17 139  15
Diastolic blood pressure (mmHg) 81  98 1  10 82  87 9  10
2-h glucose (mmol/l) 8.4  2.0 8.4  2.1 8.1  1.8 8.8  2.2
Fasting glucose (mmol/l) 5.6  0.6 5.7  0.5 5.6  0.6 5.6  0.5
Total cholesterol (mmol/l) 4.7  1.0 4.7  0.9 4.8  1.0 4.7  1.1
HDL cholesterol (mmol/l) 1.3 (1.1–1.4) 1.3 (1.1–1.5) 1.3 (1.1–1.5) 1.2 (1.1–1.4)
Triglycerides (mmol/l) 1.3 (1.0–1.8) 1.2 (1.0–1.7) 1.3 (0.9–1.7) 1.4 (0.8–1.9)
Categorical data are n (column percent), parametric continuous data as mean  SD, and nonparametric data as median (interquartile range).
Physical activity and glucose tolerance
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Yates and Associates
DIABETES CARE, VOLUME 32, NUMBER 8, AUGUST 2009 1409such as the DESMOND program (8–10).
However, larger multicentered random-
ized controlled trials are needed to con-
ﬁrm the efﬁcacy and cost-effectiveness of
this approach for preventing type 2 dia-
betes in at-risk populations.
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